OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Calreticulin as a marker and therapeutic target for cancer
Meilan Zhang, Juan Xiao, Jiangrong Liu, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1393-1404
Closed Access | Times Cited: 17
Meilan Zhang, Juan Xiao, Jiangrong Liu, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 5, pp. 1393-1404
Closed Access | Times Cited: 17
Showing 17 citing articles:
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions
Xingchen Li, Wenzhi Tian, Zhongxing Jiang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 18
Xingchen Li, Wenzhi Tian, Zhongxing Jiang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 18
Lenalidomide-utilizing self-assembled immunogenic cell death-inducing heparin/doxorubicin nanocomplex for anticancer immunotherapy
Minho Seo, Yun‐Hwa Jeong, Bison Seo, et al.
Nano Today (2025) Vol. 62, pp. 102677-102677
Closed Access | Times Cited: 1
Minho Seo, Yun‐Hwa Jeong, Bison Seo, et al.
Nano Today (2025) Vol. 62, pp. 102677-102677
Closed Access | Times Cited: 1
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 5
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 5
Approaches to selective and potent inhibition of glioblastoma by vanadyl complexes: Inducing mitotic catastrophe and methuosis
Sha Xu, Huixue Liu, Xin Li, et al.
Journal of Inorganic Biochemistry (2024) Vol. 257, pp. 112610-112610
Closed Access | Times Cited: 5
Sha Xu, Huixue Liu, Xin Li, et al.
Journal of Inorganic Biochemistry (2024) Vol. 257, pp. 112610-112610
Closed Access | Times Cited: 5
DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1
Siyu Chen, Wenxiang Zhang, Xiao Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Siyu Chen, Wenxiang Zhang, Xiao Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer
Xiaoxi Li, Nan Su, Haining Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Xiaoxi Li, Nan Su, Haining Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review
Clémentine Fulbert, Tristan Doussineau, Léna Carmès, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 519-519
Open Access
Clémentine Fulbert, Tristan Doussineau, Léna Carmès, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 519-519
Open Access
State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
A Transformable Specific‐Responsive Peptide for One‐Step Synergistic Therapy of Bladder Cancer
Ziqi Wang, Tianrui Qu, Zhishuai Zhang, et al.
Small (2024) Vol. 20, Iss. 35
Closed Access | Times Cited: 2
Ziqi Wang, Tianrui Qu, Zhishuai Zhang, et al.
Small (2024) Vol. 20, Iss. 35
Closed Access | Times Cited: 2
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 2
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 2
Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy
Zhenzhen Li, Bingqian Han, Menghui Qi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189172-189172
Closed Access | Times Cited: 1
Zhenzhen Li, Bingqian Han, Menghui Qi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189172-189172
Closed Access | Times Cited: 1
Enhanced Antiglioma Effect by a Vitamin D3-Inserted Lipid Hybrid Neutrophil Membrane Biomimetic Multimodal Nanoplatform
Weichong He, Wei Lv, Linfeng Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 52, pp. 35559-35574
Closed Access | Times Cited: 1
Weichong He, Wei Lv, Linfeng Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 52, pp. 35559-35574
Closed Access | Times Cited: 1
Calreticulin surface presentation: a signal for natural killer cells to attack
Jasmine P Castellanos, Joseph C. Genereux
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Jasmine P Castellanos, Joseph C. Genereux
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Potential biomarkers and drug targets in glycoproteome of MCF-7 breast cancer cells based on proteomics and bioinformatics strategies Running title: Protein drug targets in MCF-7 cell line
Zahra Niknam, Fatemeh Sadat Sadjjadi, Zahra Molavi, et al.
Research Square (Research Square) (2024)
Open Access
Zahra Niknam, Fatemeh Sadat Sadjjadi, Zahra Molavi, et al.
Research Square (Research Square) (2024)
Open Access
Machine learning‐based identification of a cell death‐related signature associated with prognosis and immune infiltration in glioma
Quanwei Zhou, Fei Wu, Wenlong Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access
Quanwei Zhou, Fei Wu, Wenlong Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access
O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications
Lu Xia, Jie Mei, Min Huang, et al.
Translational Oncology (2024) Vol. 51, pp. 102220-102220
Closed Access
Lu Xia, Jie Mei, Min Huang, et al.
Translational Oncology (2024) Vol. 51, pp. 102220-102220
Closed Access
Cell death-related signature associated with prognosis and immune infiltration in glioma
Quanwei Zhou, Tuo Cao, Wenlong Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Quanwei Zhou, Tuo Cao, Wenlong Zhang, et al.
Research Square (Research Square) (2023)
Open Access
